stockrowHyperfine, Inc. (HYPR) vs Zomedica Corp. (ZOMDF)
- Hyperfine, Inc. HYPR 0.70 +1.45%
- Zomedica Corp. ZOMDF 0.09 0.00%
Hyperfine, Inc. and Zomedica Corp. are both Medical Devices companies. Zomedica Corp. is the larger, with a market value of $95.4M against $72.7M — 1.3× the size. Hyperfine, Inc. grew revenue faster over the last twelve months: 53.2% against 31.3%. Zomedica Corp. has the higher net margin (−41.4% vs −210.8%) and the higher return on invested capital (−17.1% vs −401.8%). Across the 17 metrics below, Zomedica Corp. leads on 14 and Hyperfine, Inc. on 3.
Valuation
Profitability
| Metric | HYPR | ZOMDF | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.41% | 63.96% | 57.76% |
| Operating margin | (203.27%) | (45.43%) | (15.07%) |
| Net margin | (210.75%) | (41.35%) | (14.45%) |
| Free cash flow margin | (166.48%) | (34.81%) | (3.88%) |
| Return on equity | (96.97%) | (14.28%) | (10.35%) |
| Return on assets | (64.40%) | (13.01%) | (17.26%) |
| Return on invested capital | (401.79%) | (17.12%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack